Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study

Molly M. Shores, Mary L. Biggs, Alice M. Arnold, Nicholas L. Smith, W. T. Longstreth, Jorge Kizer, Calvin H. Hirsch, Anne R. Cappola, Alvin M. Matsumoto

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Context: Low testosterone (T) is associated with prevalent cardiovascular disease (CVD) and mortality. DHT, a more potent androgen, may also be associated with CVD and mortality, but few studies have examined this. Objective: The study objective was to examine whether T and DHT are risk factors for incident CVD and mortality. Design: In a longitudinal cohort study, we evaluated whether total T, calculated free T (cFT), DHT, and calculated free DHT were associated with incident CVD and mortality in men in the Cardiovascular Health Study (mean age 76, range 66-97 years) who were free of CVD at the time of blood collection. Main Outcome: The main outcomes were incident CVD and all-cause mortality. Results:Among1032menfollowed for amedianof 9 years, 436 incidentCVDeventsand777 deaths occurred. In models adjusted for cardiovascular risk factors, total TandcFTwerenot associated with incident CVD or all-cause mortality, whereas DHT and calculated free DHT had curvilinear associations with incident CVD (P < .002 and P = .04, respectively) and all-cause mortality (P < .001 for both). Conclusions: In a cohort of elderly men,DHTand calculated freeDHTwere associated with incident CVD and all-cause mortality. Further studies are needed to confirm these results and to clarify the underlying physiologic mechanisms.

Original languageEnglish (US)
Pages (from-to)2061-2068
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Dihydrotestosterone
Testosterone
Cardiovascular Diseases
Health
Mortality
Cardiovascular Models
Androgens
Longitudinal Studies
Blood
Cohort Studies

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Shores, M. M., Biggs, M. L., Arnold, A. M., Smith, N. L., Longstreth, W. T., Kizer, J., ... Matsumoto, A. M. (2014). Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study. Journal of Clinical Endocrinology and Metabolism, 99(6), 2061-2068. https://doi.org/10.1210/jc.2013-3576

Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study. / Shores, Molly M.; Biggs, Mary L.; Arnold, Alice M.; Smith, Nicholas L.; Longstreth, W. T.; Kizer, Jorge; Hirsch, Calvin H.; Cappola, Anne R.; Matsumoto, Alvin M.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 99, No. 6, 2014, p. 2061-2068.

Research output: Contribution to journalArticle

Shores, MM, Biggs, ML, Arnold, AM, Smith, NL, Longstreth, WT, Kizer, J, Hirsch, CH, Cappola, AR & Matsumoto, AM 2014, 'Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 6, pp. 2061-2068. https://doi.org/10.1210/jc.2013-3576
Shores, Molly M. ; Biggs, Mary L. ; Arnold, Alice M. ; Smith, Nicholas L. ; Longstreth, W. T. ; Kizer, Jorge ; Hirsch, Calvin H. ; Cappola, Anne R. ; Matsumoto, Alvin M. / Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study. In: Journal of Clinical Endocrinology and Metabolism. 2014 ; Vol. 99, No. 6. pp. 2061-2068.
@article{7bd8ed8dec4640388d76edb9323c1d08,
title = "Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study",
abstract = "Context: Low testosterone (T) is associated with prevalent cardiovascular disease (CVD) and mortality. DHT, a more potent androgen, may also be associated with CVD and mortality, but few studies have examined this. Objective: The study objective was to examine whether T and DHT are risk factors for incident CVD and mortality. Design: In a longitudinal cohort study, we evaluated whether total T, calculated free T (cFT), DHT, and calculated free DHT were associated with incident CVD and mortality in men in the Cardiovascular Health Study (mean age 76, range 66-97 years) who were free of CVD at the time of blood collection. Main Outcome: The main outcomes were incident CVD and all-cause mortality. Results:Among1032menfollowed for amedianof 9 years, 436 incidentCVDeventsand777 deaths occurred. In models adjusted for cardiovascular risk factors, total TandcFTwerenot associated with incident CVD or all-cause mortality, whereas DHT and calculated free DHT had curvilinear associations with incident CVD (P < .002 and P = .04, respectively) and all-cause mortality (P < .001 for both). Conclusions: In a cohort of elderly men,DHTand calculated freeDHTwere associated with incident CVD and all-cause mortality. Further studies are needed to confirm these results and to clarify the underlying physiologic mechanisms.",
author = "Shores, {Molly M.} and Biggs, {Mary L.} and Arnold, {Alice M.} and Smith, {Nicholas L.} and Longstreth, {W. T.} and Jorge Kizer and Hirsch, {Calvin H.} and Cappola, {Anne R.} and Matsumoto, {Alvin M.}",
year = "2014",
doi = "10.1210/jc.2013-3576",
language = "English (US)",
volume = "99",
pages = "2061--2068",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study

AU - Shores, Molly M.

AU - Biggs, Mary L.

AU - Arnold, Alice M.

AU - Smith, Nicholas L.

AU - Longstreth, W. T.

AU - Kizer, Jorge

AU - Hirsch, Calvin H.

AU - Cappola, Anne R.

AU - Matsumoto, Alvin M.

PY - 2014

Y1 - 2014

N2 - Context: Low testosterone (T) is associated with prevalent cardiovascular disease (CVD) and mortality. DHT, a more potent androgen, may also be associated with CVD and mortality, but few studies have examined this. Objective: The study objective was to examine whether T and DHT are risk factors for incident CVD and mortality. Design: In a longitudinal cohort study, we evaluated whether total T, calculated free T (cFT), DHT, and calculated free DHT were associated with incident CVD and mortality in men in the Cardiovascular Health Study (mean age 76, range 66-97 years) who were free of CVD at the time of blood collection. Main Outcome: The main outcomes were incident CVD and all-cause mortality. Results:Among1032menfollowed for amedianof 9 years, 436 incidentCVDeventsand777 deaths occurred. In models adjusted for cardiovascular risk factors, total TandcFTwerenot associated with incident CVD or all-cause mortality, whereas DHT and calculated free DHT had curvilinear associations with incident CVD (P < .002 and P = .04, respectively) and all-cause mortality (P < .001 for both). Conclusions: In a cohort of elderly men,DHTand calculated freeDHTwere associated with incident CVD and all-cause mortality. Further studies are needed to confirm these results and to clarify the underlying physiologic mechanisms.

AB - Context: Low testosterone (T) is associated with prevalent cardiovascular disease (CVD) and mortality. DHT, a more potent androgen, may also be associated with CVD and mortality, but few studies have examined this. Objective: The study objective was to examine whether T and DHT are risk factors for incident CVD and mortality. Design: In a longitudinal cohort study, we evaluated whether total T, calculated free T (cFT), DHT, and calculated free DHT were associated with incident CVD and mortality in men in the Cardiovascular Health Study (mean age 76, range 66-97 years) who were free of CVD at the time of blood collection. Main Outcome: The main outcomes were incident CVD and all-cause mortality. Results:Among1032menfollowed for amedianof 9 years, 436 incidentCVDeventsand777 deaths occurred. In models adjusted for cardiovascular risk factors, total TandcFTwerenot associated with incident CVD or all-cause mortality, whereas DHT and calculated free DHT had curvilinear associations with incident CVD (P < .002 and P = .04, respectively) and all-cause mortality (P < .001 for both). Conclusions: In a cohort of elderly men,DHTand calculated freeDHTwere associated with incident CVD and all-cause mortality. Further studies are needed to confirm these results and to clarify the underlying physiologic mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84902330217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902330217&partnerID=8YFLogxK

U2 - 10.1210/jc.2013-3576

DO - 10.1210/jc.2013-3576

M3 - Article

C2 - 24628549

AN - SCOPUS:84902330217

VL - 99

SP - 2061

EP - 2068

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -